Denali Therapeutics (DNLI) director granted RSUs and stock options in new equity awards
Rhea-AI Filing Summary
Denali Therapeutics director Jennifer E. Cook received equity compensation consisting of restricted stock units and stock options. She acquired 6,408 shares of Common Stock at a price of $0.00 per share as a grant, bringing her direct Common Stock holdings to 32,483 shares.
Each of these 6,408 shares is represented by a restricted stock unit and a contingent right to receive one share of Common Stock, with 100% of the units vesting upon the earlier of the one-year anniversary of the grant date or the day preceding Denali’s next annual meeting of stockholders. She also received a stock option covering 19,226 shares of Common Stock at an exercise price of $19.66 per share, which will vest on the same schedule.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 6,408 shares
Net Buy
2 txns
Insider
Cook Jennifer E.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 19,226 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 6,408 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 19,226 shares (Direct);
Common Stock — 32,483 shares (Direct)
Footnotes (3)
- F1. Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
- F2. Includes 6,408 unvested RSUs.
- F3. 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
Key Figures
RSU shares granted: 6,408 shares
Post-grant common holdings: 32,483 shares
Option shares granted: 19,226 shares
+3 more
6 metrics
RSU shares granted
6,408 shares
Restricted Stock Units representing Common Stock grant on June 3, 2026
Post-grant common holdings
32,483 shares
Common Stock directly owned after RSU grant
Option shares granted
19,226 shares
Stock option covering Common Stock granted on June 3, 2026
Option exercise price
$19.66 per share
Exercise price for 19,226-share stock option
RSU vesting trigger
1 year / pre-meeting
Vests on one-year anniversary or day before next annual meeting
Option expiration
June 3, 2036
Expiration date for stock option on Common Stock
Key Terms
Restricted Stock Unit ("RSU"), contingent right, vest, Stock Option (right to buy), +1 more
5 terms
Restricted Stock Unit ("RSU") financial
"Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock"
contingent right financial
"and a contingent right to receive one share of common stock of the Issuer"
vest financial
"100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Stock Option (right to buy) financial
"Stock Option (right to buy) with an exercise price of 19.6600"
annual meeting of stockholders financial
"or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Denali Therapeutics (DNLI) director Jennifer Cook acquire in this Form 4?
Jennifer Cook received equity compensation grants, not open-market purchases. She acquired 6,408 shares of Common Stock through restricted stock units and a stock option covering 19,226 shares. These awards represent standard director compensation rather than discretionary trading activity.
What are the terms of Jennifer Cook’s restricted stock units from Denali Therapeutics (DNLI)?
The grant consists of 6,408 restricted stock units, each tied to one share of Common Stock. One hundred percent of the units vest upon the earlier of the one-year anniversary of the grant date or the day preceding Denali’s next annual meeting of stockholders after the grant date.
What are the key details of the stock option granted to Jennifer Cook by Denali Therapeutics (DNLI)?
Jennifer Cook received a stock option for 19,226 shares of Common Stock with an exercise price of $19.66 per share. All option shares will vest upon the earlier of one year from the grant date or the day before Denali’s next annual meeting of stockholders following the grant.
Was Jennifer Cook’s Form 4 transaction in Denali Therapeutics (DNLI) a market buy or sell?
The Form 4 reflects compensation-related acquisitions, not market trades. Both the 6,408 restricted stock units and the 19,226-share stock option were granted to her at a price of $0.00 per share as equity awards for service, rather than open-market buying or selling.